SNN

IMPLANT

Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to payments for medical devices, including complexity adjustment criteria. Issues related to Most Favored Nation drug pricing. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. Monitored issues related to price transparency. Monitored issues related to tariffs. Issues related to the Section 301 forced labor investigation.

Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to tariffs. Issues related to the USMCA trade agreement. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.

Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to payments for medical devices. Issues related to Most Favored Nation drug pricing. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. Monitored issues related to price transparency. Monitored issues related to tariffs.

Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.

Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to tariffs. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.

Monitored issues related to tariffs. Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Issues related to Most Favored Nation drug pricing. Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations. Monitored issues related to price transparency.

Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.

Issues related to tariffs. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests. Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025. Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.

Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.

Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid. Issues related to Most Favored Nation drug pricing. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitored issues related to price transparency. Monitored issues related to tariffs.